Alan Russell

Chief Scientific Officer

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Alan Russell is the Chief Scientific Officer at Edgewise Therapeutics Inc in the United States. His research interests include mechanisms underlying muscle contraction, the effects of pharmacological interventions in muscular dystrophies, and mitochondrial function in cardiac conditions. Recent publications focus on the impact of deflazacort on muscle permeability, as well as genetic influences on atrial function and skeletal muscle protection in animal models.

Articles (5)

Year:

2025

Year:

2025

Year:

2023

Year:

2021

Year:

2020

Collaborators (2)

Daniel Michele

Professor

University of Michigan

UNITED STATES

View details

Susan Brooks

Professor

University of Michigan

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Alan Russell

Research Interests

Explore related searches

Contact this professor

About

Articles (5)

Short-term daily deflazacort decreases membrane permeability and increases maximum force in mdx mice

Heterozygous MYH7 R403Q mutation impairs left atrial mitochondrial function in a Yucatan mini-pig model of genetic nonobstructive hypertrophic cardiomyopathy

Modulating fast skeletal muscle contraction protects skeletal muscle in animal models of Duchenne muscular dystrophy

Elevation of fast but not slow troponin I in the circulation of patients with Becker and Duchenne muscular dystrophy

Effects of a selective androgen receptor modulator (SARM), GSK2849466A, on stress urinary incontinence and bladder activity in rats with ovariectomy-induced oestrogen deficiency.

Collaborators (2)

Daniel Michele

Susan Brooks

Make your next move.